What does Elon Musk's brain chip company Neuralink do?
Neuralink, the Elon Musk company that Reuters reported on Monday is the target of a federal investigation over its animal trial program, has been trying to develop a brain chip that would enable the paralyzed to walk and the blind to see.
Here is more on what Neuralink does.
WHAT IS NEURALINK DEVELOPING?
Founded in 2016 by Musk and a group of engineers, Neuralink is building a brain chip interface that can be implanted within the skull, which it says could eventually help disabled patients to move and communicate again, and also restore vision.
Neuralink's device has a chip that processes and transmits neural signals that could be transmitted to devices like a computer or a phone.
The company hopes that a person would potentially be able to control a mouse, keyboard or other computer functions like text messaging with their thoughts.
"First @Neuralink product will enable someone with paralysis to use a smartphone with their mind faster than someone using thumbs," Musk said in April 2021.
Neuralink also believes its device will eventually be able to restore neural activity inside the body, allowing those with spinal cord injuries to move limbs. The San Francisco and Austin-based company also aspires to cure neurological conditions such as Alzheimer's and dementia.
WHAT PROGRESS HAS NEURALINK MADE?
Neuralink has produced several examples of testing aspects of its technology successfully on animals, including a video in 2021 that showed a macaque playing a simple videogame after being implanted with a brain chip. In a presentation webcast last week, the company showcased improvements in the speed and capabilities of the chip.
Neuralink has yet to secure U.S. regulatory approval to move to human trials - unlike competitor Synchron, which has less ambitious goals for its medical advances. Neuralink has missed Musk's publicly stated deadlines to start human trials and this year submitted its application to the Food and Drug Administration to begin them. Musk said last week he believes Neuralink can start human clinical trials in six months.
(Reporting by Chavi Mehta in Bengaluru and Rachael Levy in Washington; editing by Greg Roumeliotis and Rosalba O'Brien)
RISKIN REPORTS
CTVNews.ca Top Stories
WHO: COVID-19 still an emergency but nearing 'inflection' point
The coronavirus remains a global health emergency, the World Health Organization chief said Monday, after a key advisory panel found the pandemic may be nearing an 'inflection point' where higher levels of immunity can lower virus-related deaths.

Federal departments failed to spend $38B on promised programs, services last year
The federal government failed to spend tens of billions of dollars in the last fiscal year on promised programs and services, including new military equipment, affordable housing and support for veterans.
Quebec Cardinal Marc Ouellet set to retire after overseeing Vatican's bishops' office
Marc Ouellet, the Quebec cardinal who oversaw the Vatican's powerful bishops' office and has been recently accused of sexual misconduct, is retiring.
NDP to call for emergency debate in House of Commons over private health care
Federal New Democrat Leader Jagmeet Singh says he will call on the House of Commons to hold an emergency debate on the privatization of health care.
23 vehicles towed, dozens of tickets issued as rally marks one-year anniversary of 'Freedom Convoy' in Ottawa
OPS and Ottawa Bylaw officers issued 192 parking tickets and 67 Provincial Offences Notices in downtown Ottawa this weekend, as people gathered marked the one-year anniversary of the 'Freedom Convoy'.
Boris Johnson says Putin said he could hit him with missile
Former U.K. prime minister Boris Johnson said that President Vladimir Putin didn't seem serious about avoiding war in the days before Russia invaded Ukraine, and at one point told the British leader it would be easy to kill him with a missile.
Once-in-a-lifetime discovery: Indigenous jacket more than a century old turns up in small U.K. town
When 1990s suede fringe jackets started making a comeback last year, a U.K.-based vintage clothing company decided to order four tonnes of suede from a supplier in the United States. Along with that shipment came a once-in-a lifetime discovery.
Parliamentarians return to House of Commons facing rocky economic year
Economic matters will be top of mind for parliamentarians as they return to Ottawa to kick off a new year in federal politics.
Suicide bomber kills 34, wounds 150 at mosque in Pakistan
A suicide bomber detonated explosives during crowded prayers at a mosque inside a police compound in Pakistan on Monday, causing the roof to cave in. At least 34 people were killed and 150 wounded, officials said.